In previous study, 2,5-dimethylcelecoxib (DM-celecoxib) can activate GSK-3α and β by inhibiting Akt, to prevent left ventricular hypertrophy and fibrosis [36]. The gene discussed is GSK3A; the disease is left ventricular hypertrophy.